Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Ocrelizumab Antibody (2D729)

😃Good
Catalog No. TMAS-00066
Alias Ocrevus

Anti-Ocrelizumab Antibody (2D729) is a Rabbit antibody targeting Ocrelizumab. Anti-Ocrelizumab Antibody (2D729) can be used in ELISA, Sandwich ELISA, Competitive ELISA.

Anti-Ocrelizumab Antibody (2D729)

Anti-Ocrelizumab Antibody (2D729)

😃Good
Catalog No. TMAS-00066Alias Ocrevus
Anti-Ocrelizumab Antibody (2D729) is a Rabbit antibody targeting Ocrelizumab. Anti-Ocrelizumab Antibody (2D729) can be used in ELISA, Sandwich ELISA, Competitive ELISA.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
40 μg$3057-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Ocrelizumab Antibody (2D729) is a Rabbit antibody targeting Ocrelizumab. Anti-Ocrelizumab Antibody (2D729) can be used in ELISA, Sandwich ELISA, Competitive ELISA.
SynonymsOcrevus
Ig Type
IgG, κ
Clone
2D729
Specificity
Ocrelizumab
Application
Recommended Dose
ELISA: 0.01-1 µg/ml; Sandwich ELISA: 0.5-2 μg/ml; Competitive ELISA: 1-10 μg/ml
Antibody Type
Monoclonal
Host SpeciesRabbit
PurificationProtein A affinity column
AppearanceLyophilized. Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
FormulationLyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
Research BackgroundOcrelizumab is a recombinant humanized monoclonal IgG1 antibody that selectively targets B-cells expressing the CD20 antigen. It is indicated for the treatment of primary progressive or relapsing forms of multiple sclerosis (MS). Compared to non-humanized CD20 antibodies like rituximab, ocrelizumab is anticipated to have a lower potential for immunogenicity with repeated infusions. This improved benefit-to-risk profile is beneficial for patients with MS.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Ocrelizumab
Chemical Properties
Stability & Storage
Stability & StorageThe lyophilized product store at -20°C or -80°C for 12 months. The reconstituted antibody can be stored at 2°C-8°C for 2-3 weeks or at -20°C for 12 months. Avoid repeated freeze-thaw cycles.
TransportShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-Ocrelizumab Antibody (2D729) | purchase Anti-Ocrelizumab Antibody (2D729) | Anti-Ocrelizumab Antibody (2D729) cost | order Anti-Ocrelizumab Antibody (2D729)